Company: CERO
Filing Date: 2025-01-21
Form Type: S-1/A
Source: 0001213900-25-004742
Chunk: 2

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-01-21
Form: S-1/A
Chunk 2
---
000,000 Shares of Common Stock Up to 8,000,000 Shares of Common Stock Issuable Upon Exercise of Pre-Funded Warrants and Common Warrants We are offering up to 4,000,000 shares of our common stock, par value $0.0001 per share (“Common Stock”), together with 4,000,000 new common warrants (the “Offered Common Warrants”) to purchase up to an aggregate of 4,000,000 shares of our Common Stock and an aggregate of 4,000,000 shares of our Common Stock issuable upon exercise of the Offered Common Warrants. Each share of Common Stock, or pre-funded warrant in lieu thereof (“Pre-Funded Warrants”), is being sold together with an Offered Common Warrant to purchase one share of Common Stock. Each Common Offered Warrant will have an exercise price of $2.34, will be immediately exercisable and will expire on the fifth anniversary of the original issuance date. We are also offering to certain purchasers whose purchase of shares of Common Stock in this offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding Common Stock immediately following the consummation of this offering, the opportunity to purchase, if any such purchaser so chooses, Pre-Funded Warrants to purchase up to 4,000,000 shares of Common Stock, in lieu of shares of Common Stock that would otherwise result in such purchaser’s beneficial ownership exceeding 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding Common Stock. The public offering price of each Pre-Funded Warrant and accompanying Offered Common Warrant will be equal to the price at which one share of Common Stock and accompanying Offered Common Warrant is sold to the public in this offering, minus $0.001, and the exercise price of each pre-funded warrant will be $0.001 per share. The Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full. The shares of Common Stock, or Pre-Funded Warrants in lieu thereof, and the accompanying Offered Common Warrants can only be purchased together in this offering but will be issued separately and will be immediately separable upon issuance. This offering will terminate on February 15, 2025